Arkolith/Insider Trading/HQL/Form 4

Weinstein Boaz

10% Ownerabrdn Life Sciences Investors (HQL) · full profile →Form 4 · filed Apr 23, 2024
Net Buying
Open-Market Buys
$660K
Open-Market Sells
$0
Net Open-Market Flow
$660K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 23, 2024Buy(P)48K$13.15$634K2.8M
Apr 22, 2024Buy(P)2K$12.88$26K2.7M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001510281-24-000252) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML